We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $28.46 · 14 analysts
Stored first · Google News · Yahoo Finance (English)
Acadia Healthcare stock hits 52-week high at $32.82 - Investing.com
Acadia Healthcare stock hits 52-week high at $32.82 Investing.com
Is It Too Late to Buy Acadia Healthcare Co Inc (ACHC) After 3.4% Rally? GF Value Says Undervalued - GuruFocus
Is It Too Late to Buy Acadia Healthcare Co Inc (ACHC) After 3.4% Rally? GF Value Says Undervalued GuruFocus
ACHC: Lowering target price to $33.00
ACHC Maintained by Keybanc -- Price Target Raised to $40.00 - GuruFocus
ACHC Maintained by Keybanc -- Price Target Raised to $40.00 GuruFocus
3 Unpopular Stocks We Find Risky
Acadia Healthcare Company Stock Short Interest Rises to 37.85% - Quiver Quantitative
Acadia Healthcare Company Stock Short Interest Rises to 37.85% Quiver Quantitative
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 29. | After market close (AMC) | $0.37 | — | — | $847.13M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $0.09 | — | — | $770.51M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $2.42 | — | — | $2.38B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $1.68 | — | — | $1.56B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 05. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2026. 05. 04. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 05. 02. | Cantor Fitzgerald | — | Maintain | Neutral → Neutral | — | Cantor Fitzgerald: Neutral |
| 2026. 05. 01. | Barclays | — | Maintain | Equal-Weight → Equal-Weight | — | Barclays: Equal-Weight |
| 2026. 04. 29. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2026. 04. 18. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.